Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-17,443
Closed -$1.08M 1023
2026
Q1
$1.08M Buy
17,443
+7,785
+81% +$542K 0.19% 152
2025
Q4
$641K Sell
9,658
-8,710
-47% -$563K 0.1% 395
2025
Q3
$1.24M Buy
+18,368
New +$1.45M 0.19% 141
2025
Q2
Sell
-8,533
Closed -$583K 953
2025
Q1
$583K Buy
8,533
+5,436
+176% +$444K 0.09% 419
2024
Q4
$241K Sell
3,097
-12,500
-80% -$925K 0.04% 708
2024
Q3
$1.05M Buy
15,597
+8,529
+121% +$700K 0.23% 108
2024
Q2
$801K Buy
+7,068
New +$894K 0.15% 255
2023
Q3
Sell
-2,316
Closed -$298K 771
2023
Q2
$298K Buy
+2,316
New +$280K 0.08% 454
2022
Q1
Sell
-1,752
Closed -$235K 548
2021
Q4
$235K Buy
+1,752
New +$252K 0.14% 311
2020
Q3
Sell
-3,236
Closed -$328K 216
2020
Q2
$328K Buy
+3,236
New +$289K 0.43% 90
2019
Q2
Sell
-15,796
Closed -$470K 471
2019
Q1
$470K Buy
+15,796
New +$555K 0.27% 125
2018
Q4
Sell
-19,556
Closed -$699K 564
2018
Q3
$699K Buy
+19,556
New +$606K 0.3% 67
2017
Q4
Sell
-78,000
Closed -$954K 718
2017
Q3
$954K Buy
78,000
+60,400
+343% +$1.07M 0.27% 79
2017
Q2
$322K Buy
+17,600
New +$325K 0.11% 384

Other funds holding DXCM

Fox Run Management's DXCM Position: Q2 2026 in Review

Fox Run Management sold out of DexCom (DXCM) in Q2 2026, closing a stake of 17,443 shares — an estimated $1.08M sold.

Fox Run Management first reported a position in DXCM in Q2 2017 and held it in 14 quarters. The position peaked at $1.24M in Q3 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Fox Run Management reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Fox Run Management sold 17,443 DexCom shares in Q2 2026, an estimated $1.08M.
  • Fox Run Management first reported a position in DexCom in Q2 2017 and held it in 14 quarters.
  • Fox Run Management's DexCom position peaked at $1.24M in Q3 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.